TIAA CREF Investment Management’s Kura Oncology KURA Stock Holding History

TIAA CREF Investment Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$922K	Buy	55,603 +8,813	+19%	+$136K	﹤0.01%	2356
2018 Q4	$657K	Buy	46,790 +5,127	+12%	+$67.9K	﹤0.01%	2462
2018 Q3	$729K	Sell	41,663 -5,699	-12%	-$109K	﹤0.01%	2564
2018 Q2	$862K	Sell	47,362 -514	-1%	-$8.71K	﹤0.01%	2552
2018 Q1	$898K	Buy	47,876 +311	+0.7%	+$6.05K	﹤0.01%	2495
2017 Q4	$728K	Buy	47,565 +915	+2%	+$13.5K	﹤0.01%	2618
2017 Q3	$697K	Buy	46,650 +5,248	+13%	+$49.3K	﹤0.01%	2681
2017 Q2	$385K	Buy	+41,402	New	+$377K	﹤0.01%	2975

Other funds holding KURA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

TIAA CREF Investment Management's KURA Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Kura Oncology (KURA) stake by 19% in Q1 2019, buying an estimated $136K and bringing the position to 55,603 shares worth $922K. The position accounts for ﹤0.01% of the portfolio, ranked #2356.

TIAA CREF Investment Management first reported a position in KURA in Q2 2017 and has held it in 8 quarters since. 104 funds tracked by Wall St. Rank hold KURA as of Q1 2019.

TIAA CREF Investment Management held 55,603 shares of Kura Oncology worth $922K as of Q1 2019.
TIAA CREF Investment Management bought 8,813 Kura Oncology shares in Q1 2019, an estimated $136K.
Kura Oncology made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2356 holding.
TIAA CREF Investment Management first reported a position in Kura Oncology in Q2 2017 and has held it in 8 quarters since.
104 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.